2023 -- S 0810 | |
======== | |
LC000861 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2023 | |
____________ | |
A N A C T | |
RELATING TO FOOD AND DRUGS -- THE EDWARD O. HAWKINS AND THOMAS C. | |
SLATER MEDICAL MARIJUANA ACT | |
| |
Introduced By: Senators Lombardo, DiPalma, Ciccone, Pearson, and Miller | |
Date Introduced: March 23, 2023 | |
Referred To: Senate Judiciary | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 21-28.6-3 of the General Laws in Chapter 21-28.6 entitled "The |
2 | Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act" is hereby amended to read as |
3 | follows: |
4 | 21-28.6-3. Definitions. |
5 | For the purposes of this chapter: |
6 | (1) “Authorized purchaser” means a natural person who is at least twenty-one (21) years |
7 | old and who is registered with the department of health for the purposes of assisting a qualifying |
8 | patient in purchasing marijuana from a compassion center. An authorized purchaser may assist no |
9 | more than one patient, and is prohibited from consuming marijuana obtained for the use of the |
10 | qualifying patient. An authorized purchaser shall be registered with the department of health and |
11 | shall possesses a valid registry identification card. |
12 | (2) “Cannabis” means all parts of the plant of the genus marijuana, also known as marijuana |
13 | sativa L. whether growing or not; the seeds thereof; the resin extracted from any part of the plant; |
14 | and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, |
15 | or resin regardless of cannabinoid content or cannabinoid potency including “marijuana,” and |
16 | “industrial hemp” or “industrial hemp products” which satisfy the requirements of chapter 26 of |
17 | title 2. |
18 | (3) “Cannabis testing laboratory” means a third-party analytical testing laboratory licensed |
| |
1 | by the department of health, in coordination with the department of business regulation, to collect |
2 | and test samples of cannabis. |
3 | (4) “Cardholder” means a person who has been registered or licensed with the department |
4 | of health or the department of business regulation pursuant to this chapter and possesses a valid |
5 | registry identification card or license. |
6 | (5) “Commercial unit” means a building, or other space within a commercial or industrial |
7 | building, for use by one business or person and is rented or owned by that business or person. |
8 | (6)(i) “Compassion center” means a not-for-profit corporation, subject to the provisions of |
9 | chapter 6 of title 7, and is licensed under § 21-28.6-12, that acquires, possesses, cultivates, |
10 | manufactures, delivers, transfers, transports, supplies, or dispenses medical marijuana, and/or |
11 | related supplies and educational materials, to patient cardholders and/or their registered caregiver |
12 | cardholder or authorized purchaser. |
13 | (ii) “Compassion center cardholder” means a principal officer, board member, employee, |
14 | volunteer, or agent of a compassion center who has registered with the department of business |
15 | regulation and has been issued and possesses a valid, registry identification card. |
16 | (7) “Debilitating medical condition” means: |
17 | (i) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune |
18 | deficiency syndrome, Hepatitis C, post-traumatic stress disorder, or the treatment of these |
19 | conditions; |
20 | (ii) A chronic or debilitating disease or medical condition, or its treatment, that produces |
21 | one or more of the following: cachexia or wasting syndrome; severe, debilitating, chronic pain; |
22 | severe nausea; seizures, including but not limited to, those characteristic of epilepsy; or severe and |
23 | persistent muscle spasms, including but not limited to, those characteristic of multiple sclerosis or |
24 | Crohn’s disease; or agitation of Alzheimer’s Disease; or |
25 | (iii) Any other medical condition or its treatment approved by the department of health, as |
26 | provided for in § 21-28.6-5. |
27 | (8) “Department of business regulation” means the office of cannabis regulation within the |
28 | Rhode Island department of business regulation or its successor agency. |
29 | (9) “Department of health” means the Rhode Island department of health or its successor |
30 | agency. |
31 | (10) “Department of public safety” means the Rhode Island department of public safety or |
32 | its successor agency. |
33 | (11) “Dried marijuana” means the dried leaves and flowers of the marijuana plant as |
34 | defined by regulations promulgated by the department of business regulation. |
| LC000861 - Page 2 of 6 |
1 | (12) “Dwelling unit” means the room, or group of rooms, within a residential dwelling used |
2 | or intended for use by one family or household, or by no more than three (3) unrelated individuals, |
3 | with facilities for living, sleeping, sanitation, cooking, and eating. |
4 | (13) “Equivalent amount” means the portion of usable marijuana, be it in extracted, edible, |
5 | concentrated, or any other form, found to be equal to a portion of dried marijuana, as defined by |
6 | regulations promulgated by the department of business regulation. |
7 | (14) “Immature marijuana plant” means a marijuana plant, rooted or unrooted, with no |
8 | observable flower or buds. |
9 | (15) “Licensed medical marijuana cultivator” means a person or entity, as identified in § |
10 | 43-3-6, who or that has been licensed by the department of business regulation to cultivate medical |
11 | marijuana pursuant to § 21-28.6-16. |
12 | (16) “Marijuana” has the meaning given that term in § 21-28-1.02. |
13 | (17) “Marijuana establishment licensee” means any person or entity licensed by the |
14 | department of business regulation under this chapter whose license permits it to engage in or |
15 | conduct activities in connection with the medical marijuana program. “Marijuana establishment |
16 | licensees” shall include compassion centers, medical marijuana cultivators, and cannabis testing |
17 | laboratories. |
18 | (18) “Mature marijuana plant” means a marijuana plant that has flowers or buds that are |
19 | readily observable by an unaided visual examination. |
20 | (19) “Medical marijuana emporium” means any establishment, facility or club, whether |
21 | operated for-profit or nonprofit, or any commercial unit, at which the sale, distribution, transfer, or |
22 | use of medical marijuana or medical marijuana products is proposed and/or occurs to, by or among |
23 | registered patients, registered caregivers, authorized purchaser cardholders or any other person. |
24 | This shall not include a compassion center regulated and licensed by the department of business |
25 | regulation pursuant to the terms of this chapter. |
26 | (20) “Medical marijuana” means marijuana and marijuana products that satisfy the |
27 | requirements of this chapter and have been given the designation of “medical marijuana” due to |
28 | dose, potency, form. Medical marijuana products are only available for use by patient cardholders, |
29 | and may only be sold to or possessed by patient cardholders, or their registered caregiver, or |
30 | authorized purchaser in accordance with this chapter. Medical marijuana may not be sold to, |
31 | possessed by, manufactured by, or used except as permitted under this chapter. |
32 | (21) “Medical marijuana plant tag set” or “plant tag” means any tag, identifier, registration, |
33 | certificate, or inventory tracking system authorized or issued by the department or which the |
34 | department requires be used for the lawful possession and cultivation of medical marijuana plants |
| LC000861 - Page 3 of 6 |
1 | in accordance with this chapter. |
2 | (22) “Medical use” means the acquisition, possession, cultivation, manufacture, use, |
3 | delivery, transfer, or transportation of medical marijuana or paraphernalia relating to the |
4 | consumption of marijuana to alleviate a patient cardholder’s debilitating medical condition or |
5 | symptoms associated with the medical condition in accordance with the provisions of this chapter. |
6 | (23) “Practitioner” means a person who is licensed with authority to prescribe drugs |
7 | pursuant to chapters 34, 37, and 54 of title 5, who may provide a qualifying patient with a written |
8 | certification in accordance with regulations promulgated by the department of health. |
9 | (24) “Primary caregiver” means a natural person who is at least twenty-one (21) years old |
10 | who is registered under this chapter in order to, and who may assist one qualifying patient, but no |
11 | more than five (5) qualifying patients, with their medical use of marijuana, provided that a qualified |
12 | patient may also serve as his or her own primary caregiver subject to the registration and |
13 | requirements set forth in § 21-28.6-4. |
14 | (25) “Qualifying patient” means a person who has been certified by a practitioner as having |
15 | a debilitating medical condition and is a resident of Rhode Island or an animal who has been |
16 | certified by a veterinary practitioner as having a debilitating medical condition. |
17 | (26) “Registry identification card” means a document issued by the department of health |
18 | or the department of business regulation, as applicable, that identifies a person as a registered |
19 | qualifying patient, a registered primary caregiver, or authorized purchaser, or a document issued |
20 | by the department of business regulation that identifies a person as a registered principal officer, |
21 | board member, employee, volunteer, or agent of a compassion center, licensed medical marijuana |
22 | cultivator, cannabis testing lab, or any other medical marijuana licensee. |
23 | (27) “Unusable marijuana” means marijuana seeds, stalks, and unusable roots and shall not |
24 | count towards any weight-based possession limits established in this chapter. |
25 | (28) “Usable marijuana” means the leaves and flowers of the marijuana plant, and any |
26 | mixture or preparation thereof, but does not include the seeds, stalks, and roots of the plant. |
27 | (29) "Veterinary practitioner" means a person licensed to practice veterinary medicine |
28 | pursuant to chapter 25 of title 5, who may provide a qualifying patient with a written certification |
29 | in accordance with regulations promulgated by the department of health. |
30 | (29)(30) “Wet marijuana” means the harvested leaves and flowers of the marijuana plant |
31 | before they have reached a dry state, as defined by regulations promulgated by the department of |
32 | health and department of business regulation. |
33 | (30)(31) “Written certification” means a statement signed by a practitioner, stating that, in |
34 | the practitioner’s professional opinion, the potential benefits of the medical use of marijuana would |
| LC000861 - Page 4 of 6 |
1 | likely outweigh the health risks for the qualifying patient. A written certification shall be made only |
2 | in the course of a bona fide, practitioner-patient relationship after the practitioner has completed a |
3 | full assessment of the qualifying patient’s medical history. The written certification shall specify |
4 | the qualifying patient’s debilitating medical condition or conditions which may include the |
5 | qualifying patient’s relevant medical records. |
6 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC000861 | |
======== | |
| LC000861 - Page 5 of 6 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO FOOD AND DRUGS -- THE EDWARD O. HAWKINS AND THOMAS C. | |
SLATER MEDICAL MARIJUANA ACT | |
*** | |
1 | This act would expand the definition of "qualifying patient" to include any animal having |
2 | a debilitating medical condition as determined by a veterinarian for purposes of a recommendation |
3 | for medical marijuana. |
4 | This act would take effect upon passage. |
======== | |
LC000861 | |
======== | |
| LC000861 - Page 6 of 6 |